Abstract
The octapeptide angiotensin II is a potent vasoconstrictor and increases the release of adrenaline from the adrenal medulla and noradrenaline from the terminal reticulum of sympathetic nerves. The main source of angiotensin II in plasma is angiotensinogen, which is metabolized to angiotensin I by renin secreted from the kidneys and then to the active compound angiotensin II by a circulating angiotensin converting enzyme. There is increasing evidence, however, that angiotensin II can also be produced locally in a variety of tissues. In the heart angiotensin I, II and III are present and a messenger RNA for the synthesis of renin as well as a tissue-bound converting enzyme have been detected (Lindpainter et al. 1987). This local renin-angiotensin system seems to be involved in the regulation of cell growth and may be an important factor for the development of cardiac hypertrophy (Linz et al. 1989). It can also participate in the local control of the sympathetic tone by an activation of prejunctional angiotensin receptors on nerve terminals (Ziogas et al. 1984).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Brasch H, Sieroslawski L, Dominiak P. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. Hypertension 1993; 22: 699–704.
Brasch H. Field stimulation-induced noradrenaline release from guinea-pig atria is modulated by prejunctional a2-adrenoceptors and protein kinase C. Basic Res Cardiol 1993; 88: 545–556.
Brasch H. Pulse duration and a2-adrenoceptors modify noradrenaline release from field-stimulated atria. Eur J Pharmacol 1989; 171: 49–57.
Lindpainter K, Wilhelm MJ, Jin M, Unger T, Lang RE, Schölkens BA, Ganten D. Tissue renin-angiotensin system: focus on the heart. J Hypertens 1987; 5 (Suppl. 2): 533–538.
Linz W, Schölkens BA, Ganten D: Converting enzyme inhibition prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens A 1989; 11: 1325–1350.
Mian MA, Majewski H, Rand MJ. Facilitation of noradrenaline release by isoprenaline in rat isolated atria does not improve angiotensin II formation. Clin Exp Pharmacol Physiol 1989; 16: 905–911.
Musgrave IF, Majewski H. Effect of phorbol ester and pertussis toxin on the enhancement of noradrenaline release by angiotensin II in mouse atria. Br J Pharmacol 1989; 96: 609–616.
Scott AL, Chang RSL, Lotti VJ, Siegl PKS. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart. J Pharmacol Exp Ther 1992; 261: 931–935.
Ziogas J, Story DF, Rand MJ. Effect of locally generated angiotensin II on noradrenergic transmission in guinea-pig isolated atria. Eur J Pharmacol 1984; 106: 11–18.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brasch, H., Sieroslawski, L., Bergmann, N., Dominiak, P. (1995). In Field-Stimulated Guinea-Pig Atria an AT1-Receptor Mediated Increase of Noradrenaline Release by Angiotensin II is Seen only in the Presence of Prejunctional Autoinhibition. In: Mukhopadhyay, A.K., Raizada, M.K. (eds) Tissue Renin-Angiotensin Systems. Advances in Experimental Medicine and Biology, vol 377. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0952-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0952-7_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0954-1
Online ISBN: 978-1-4899-0952-7
eBook Packages: Springer Book Archive